Skip to content
February 22, 2025

Equity.Guru

Investment information for the new generation

Search
Latest News

GSK.NYSE

23 July 2021
GlaxoSmithKline (GSK.N) Announces Positive Headline Results from Five Phase 3…
GlaxoSmithKline (GSK.NYSE) today announced positive headline results from five studies of the Phase 3 ASCEND program, evaluating the efficacy and safety profile of daprodustat, an investigational oral hypoxia-inducible factor…
16 July 2021
GlaxoSmithKline (GSK.NYSE) Announces Positive Headline Results from Five Phase 3…
GlaxoSmithKline (GSK.NYSE) today announced positive headline results from five studies of the Phase 3 ASCEND program, evaluating the efficacy and safety profile of daprodustat, an investigational oral hypoxia-inducible factor…